FBN1 c.835C>T ;(p.L279F)

Variant ID: 15-48826304-G-A

NM_000138.4(FBN1):c.835C>T;(p.L279F)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Combating acquired resistance to MAPK inhibitors in melanoma by targeting Abl1/2-mediated reactivation of MEK/ERK/MYC signaling.

Nature Communications
Tripathi, Rakshamani R; Liu, Zulong Z; Jain, Aditi A; Lyon, Anastasia A; Meeks, Christina C; Richards, Dana D; Liu, Jinpeng J; He, Daheng D; Wang, Chi C; Nespi, Marika M; Rymar, Andrey A; Wang, Peng P; Wilson, Melissa M; Plattner, Rina R
Publication Date: 2020-10-29

Variant appearance in text: FBN1: 835C>T; L279F
PubMed Link: 33122628
Variant Present in the following documents:
  • 41467_2020_19075_MOESM12_ESM.xlsx, sheet 1
View BVdb publication page